Terms: = Head and neck cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Treatment
39 results:
1. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
2. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
[TBL] [Abstract] [Full Text] [Related]
3. β-Asarone suppresses TGF-β/Smad signaling to reduce the invasive properties in esophageal squamous cancer cells.
Hu Y; Li Z; Gong L; Song Z
Med Oncol; 2022 Sep; 39(12):243. PubMed ID: 36180656
[TBL] [Abstract] [Full Text] [Related]
4. Oleuropein inhibits invasion of squamous cell carcinoma of the head and neck through TGF-β1 signaling pathway.
Xu T; Liu X
BMC Cancer; 2022 Sep; 22(1):942. PubMed ID: 36050634
[TBL] [Abstract] [Full Text] [Related]
5. CircFOXM1 acts as a ceRNA to upregulate smad2 and promote the progression of nasopharyngeal carcinoma.
Pei S; Ma C; Chen J; Hu X; Du M; Xu T; Zhan M; Xue K; Zhang Y; Yin L; He X
Mol Genet Genomic Med; 2022 May; 10(5):e1914. PubMed ID: 35266323
[TBL] [Abstract] [Full Text] [Related]
6. GDF10 inhibits cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways.
He F; Feng G; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Zhang Z; Huang G; Takeuchi K; Murata M
Carcinogenesis; 2022 Mar; 43(2):94-103. PubMed ID: 34922336
[TBL] [Abstract] [Full Text] [Related]
7. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.
Liu F; Wu Q; Han W; Laster K; Hu Y; Ma F; Chen H; Tian X; Qiao Y; Liu H; Kim DJ; Dong Z; Liu K
Clin Transl Med; 2021 Oct; 11(10):e548. PubMed ID: 34709754
[TBL] [Abstract] [Full Text] [Related]
8. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract] [Full Text] [Related]
9. Obg-like ATPase 1 inhibited oral carcinoma cell metastasis through TGFβ/smad2 axis in vitro.
Liu J; Yang Q; Xiao KC; Dobleman T; Hu S; Xiao GG
BMC Mol Cell Biol; 2020 Sep; 21(1):65. PubMed ID: 32928102
[TBL] [Abstract] [Full Text] [Related]
10. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
[TBL] [Abstract] [Full Text] [Related]
11. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract] [Full Text] [Related]
12. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract] [Full Text] [Related]
13. Lipidome-based rapid diagnosis with machine learning for detection of TGF-β signalling activated area in head and neck cancer.
Ishii H; Saitoh M; Sakamoto K; Sakamoto K; Saigusa D; Kasai H; Ashizawa K; Miyazawa K; Takeda S; Masuyama K; Yoshimura K
Br J Cancer; 2020 Mar; 122(7):995-1004. PubMed ID: 32020064
[TBL] [Abstract] [Full Text] [Related]
14. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract] [Full Text] [Related]
15. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract] [Full Text] [Related]
16. CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/smad2/3 signaling.
Kim N; Ryu H; Kim S; Joo M; Jeon HJ; Lee MW; Song IC; Kim MN; Kim JM; Lee HJ
Sci Rep; 2019 Dec; 9(1):18100. PubMed ID: 31792315
[TBL] [Abstract] [Full Text] [Related]
17. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
Wang J; Wu M; Zheng D; Zhang H; Lv Y; Zhang L; Tan HS; Zhou H; Lao YZ; Xu HX
Acta Pharmacol Sin; 2020 Jan; 41(1):82-92. PubMed ID: 31371781
[TBL] [Abstract] [Full Text] [Related]
18. Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Pareek M; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
Oral Oncol; 2019 Jul; 94():1-7. PubMed ID: 31178202
[TBL] [Abstract] [Full Text] [Related]
19. Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells
Li Y; Huang C; Bai Q; Yu J
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30940778
[TBL] [Abstract] [Full Text] [Related]
20. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
[TBL] [Abstract] [Full Text] [Related]
[Next]
